Universal Digital Announces the Filing of Amended and Restated Financial Statements and MD&A’s 
Victory Square Technologies Reports Q2 2025 Results Highlighted by Revenue Growth, Profitability, and Portfolio Momentum 
American Aires Inc. Announces Business Continuity and Governance Actions Following Special Committee Review 
Zeebu Reaches $10 Billion Settlement Milestone, Proves Programmable Payments Are Production-Ready Early Warning Reports Issued Pursuant to National Instrument 62-103 in Connection with the Completion of Private Share Sales
TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Jack Burnett, President and a director of Ramm…
Pharvaris Reports Full Year 2020 Financial Results and Provides Business Highlights
RAPIDe-1 clinical trial enrolling, evaluating PHVS416 as an oral on-demand therapy for HAE Open IND…
Eloxx Pharmaceuticals Adds Additional Treatment Arm to Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
Fifth Treatment Arm to Evaluate Safety of ELX-02 in Combination with Kalydeco (ivacaftor) Reaffirmed Data…
Selecta Biosciences Announces Three Presentations at the Upcoming 24th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
WATERTOWN, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Lexicon Pharmaceuticals to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 6, 2021
THE WOODLANDS, Texas, April 29, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will…
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
EXTON, Pa., April 29, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”)…
Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results
MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:…
Recro to Report Financial Results for First Quarter 2021 on May 6
Conference Call and Webcast Scheduled for Thursday, May 6 at 4:30 p.m. Eastern Time MALVERN,…
Nabriva Therapeutics to Report First Quarter 2021 Financial Results and Recent Corporate Highlights on May 6, 2021
DUBLIN, Ireland, April 29, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical…
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG), today announced…
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
BURLINGAME, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage…
Spero Therapeutics to Provide Business Update and Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Oncternal Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update
SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
MARGENZA™ launched in mid-March Upcoming poster presentation of MGC018 initial Phase 1 clinical data at…
Motus GI to Release First Quarter Results and Provide a Business Update on May 13
FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Y-mAbs to Announce First Quarter 2021 Financial and Operating Results on May 6, 2021
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
AmMax Bio to Present at the BofA Securities 2021 Virtual Healthcare Conference
REDWOOD CITY, Calif., April 29, 2021 (GLOBE NEWSWIRE) — AmMax Bio, Inc. (“AmMax”), a private…
Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints
Both vonoprazan-based treatment regimens demonstrated superior eradication rates vs. a standard of care proton pump…
TELA Bio to Announce First Quarter 2021 Financial Results
MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams
After the Data Monitoring Committees’ review Infant Bacterial Therapeutics expands the enrollment criteria of The…